Correlation Between Structure Therapeutics and Nuvalent
Can any of the company-specific risk be diversified away by investing in both Structure Therapeutics and Nuvalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Structure Therapeutics and Nuvalent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Structure Therapeutics American and Nuvalent, you can compare the effects of market volatilities on Structure Therapeutics and Nuvalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Structure Therapeutics with a short position of Nuvalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Structure Therapeutics and Nuvalent.
Diversification Opportunities for Structure Therapeutics and Nuvalent
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Structure and Nuvalent is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Structure Therapeutics America and Nuvalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvalent and Structure Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Structure Therapeutics American are associated (or correlated) with Nuvalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvalent has no effect on the direction of Structure Therapeutics i.e., Structure Therapeutics and Nuvalent go up and down completely randomly.
Pair Corralation between Structure Therapeutics and Nuvalent
Given the investment horizon of 90 days Structure Therapeutics American is expected to under-perform the Nuvalent. But the stock apears to be less risky and, when comparing its historical volatility, Structure Therapeutics American is 1.04 times less risky than Nuvalent. The stock trades about -0.03 of its potential returns per unit of risk. The Nuvalent is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 8,513 in Nuvalent on August 30, 2024 and sell it today you would earn a total of 1,163 from holding Nuvalent or generate 13.66% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Structure Therapeutics America vs. Nuvalent
Performance |
Timeline |
Structure Therapeutics |
Nuvalent |
Structure Therapeutics and Nuvalent Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Structure Therapeutics and Nuvalent
The main advantage of trading using opposite Structure Therapeutics and Nuvalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Structure Therapeutics position performs unexpectedly, Nuvalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvalent will offset losses from the drop in Nuvalent's long position.Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
Nuvalent vs. Ikena Oncology | Nuvalent vs. Eliem Therapeutics | Nuvalent vs. HCW Biologics | Nuvalent vs. RenovoRx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |